US 6630124
Combination therapy with VIP antagonist
expired A61KA61K31/351A61K31/427
Quick answer
US patent 6630124 (Combination therapy with VIP antagonist) held by The United States of America, as represented by the Department of Health and Human Services expires Mon Oct 02 2023 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.
Key facts
- Applicant
- The United States of America, as represented by the Department of Health and Human Services
- Grant date
- Tue Oct 07 2003 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Oct 02 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 47
- CPC classes
- A61K, A61K31/351, A61K31/427, A61K33/243, A61K38/14